IL-12 Gene Therapy Protects Mice in Lethal Klebsiella Pneumonia

Journal of Immunology

Volumn 157, Issue 7, 1996, Pages 3006-3012

  Greenberger, Marc J ^a   Kunkel, Steven L ^a   Strieter, Robert M ^a   Lukacs, Nicholas W ^a   Bramson, Jonathan ^b   Gauldie, Jack ^b   Graham, Frank L ^b   Hitt, Mary ^b   Danforth, Jean M ^a   Standiford, Theodore J ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 12; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTICLE; BACTERIAL PNEUMONIA; BIOSYNTHESIS; CBA MOUSE; CYTOMEGALOVIRUS; DRUG ANTAGONISM; ENTEROBACTER INFECTION; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; GERMFREE ANIMAL; HUMAN ADENOVIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; KLEBSIELLA PNEUMONIAE; LUNG; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNIZATION; PROMOTER REGION;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; IMMUNIZATION, PASSIVE; INTERFERON TYPE II; INTERLEUKIN-12; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MICE; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; PNEUMONIA, BACTERIAL; PROMOTER REGIONS (GENETICS); RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030266772     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Maloney, S. B., and W. J. Williams. 1995. Epidemic nosocomial pneumonia in the intensive care unit. Clin. Chest Med. 16:209.
2. Campbell, G. D. 1994. Overview of community acquired pneumonia:prognosis and clinical features. Med. Clin. North Am. 78:1035.
3. Davies, J. 1994. Inactivation of antibiotics and dissemination of resistance genes. Science 264:375.
4. Granton, J. T., and J. T. Grossman. 1993. Community-acquired pneumonia in the elderly patient: clinical features, epidemiology, and treatment. Clin. Chest Med. 13:537.
5. Svarva, C. W., H. Ratner, and J. A. Maeland. 1985. Emergence of β-lactam multiresistant variants of Gram-negative bacilli in the presence of cefotaxime. Scand. J. Infect. Dis. 17:387.
6. Toews, G. B., G. N. Gross, and A. K. Pierce. 1980. The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice. Am. Rev. Respir. Dis. 120:559.
7. Rot, A. The role of leukocyte chemotaxis in inflammation. In Chemotactic Cytokines. S. Kunkel, I. Lindley, J. Warwick, eds. Karger, Basel, p. 263.
8. Tam, A. M., A. Ferrante, D. H. Goh, D. M. Robertson, and A. W. Cripps. 1995. Activation of the neutrophil bactericidal activity for nontypeable Haemophilus influenzae by tumor necrosis factor and lymphotoxin. Pediatr. Res. 37:155.
9. Hostoffer, R. W., I. Krukovets, and M. Berger. 1994. Enhancement by tumor necrosis factor-α of FcA receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes. J. Infect. Dis. 170:82.
10. Bober, L. A., M. J. Grace, C. Pugliese-Sivo, A. Rojas-Triana, T. Waters, C. M. Sullivan, and S. K. Narula. 1995. The effect of GM-CSF and G-CSF on human neutrophil function. Immunopharmacology 29:111.
11. Roilides, E., K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1993. Enhancement of oxidative responses and damage caused by human neutrophils to Aspergillus fumigatis hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun. 61:1185.
12. Kolls, J. K., S. Nelson, and W. R. Summer. 1993. Recombinant cytokines and pulmonary host defense. Am. J. Med. Sci. 306:330.
13. Greenberger M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, L. L. Laichalk, D. C. McGillicuddy, and T. J. Standiford. 1996. Neutralization of MIP-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173:159.
14. Stern, A. S., F. J. Podlaski, J. D. Hulmes, Y. E. Pan, P. M. Quinn, A. G. Wolitzky, P. C. Familetti, D. L. Stremio, T. Truitt, R. Chizzonite, and M. K. Gately. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87:6808.
15. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchiera. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170:827.
16. Brunda, M. J. 1994. Interleukin-12. J. Leuk. Biol. 55:280.
17. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
18. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell deficient hosts. Proc. Natl. Acad Sci. USA 90:6115.
19. Wagner, R. D., H. Steinberg, J. F. Brown, and C. J. Czuprynski. 1994. Recombinant interleukin-12 enhances resistance to mice to Listeria monocytogenes infection. Microb. Pathog. 17:175.
20. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515.
21. Stevenson, M. M., M. F. Tam, S. F. Wolfe, and A. Sher. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi is requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155: 2545.
22. Car, B. D., V. M. Eng, B. Schnyder, M. LeHir, A. N. Shakhov, G. Woerly, S. Huang, M. Aguet, T. D. Anderson, and B. Ryffel. 1995. Role of interferon-γ in interleukin 12-induced pathology in mice. Am. J. Pathol. 147:1693.
23. News and Comment. 1995. IL-12 deaths: explanation and the puzzle. Science 270:908.
24. Lotze, M. T., and H. Tahara. 1995. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Gene Ther. 2:96.
25. Bramson, J., M. Hitt, W. S. Gallichan, K. L. Rosenthal, J. Gauldie, and F. L. Graham. 1996. Construction and characterization of an adenovirus expressing IL-12. Hum. Gene Ther. 7:333.
26. Chensue, S. W., J. H. Ruth, K. Warmington, P. Lincoln, and S. L. Kunkel. 1995. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J. Immunol. 155:3546.
27. Peppel, K., D. Crawford, and B. Beutler. 1991. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J. Exp. Med. 174:1483.
28. Mohler, K. M., D. S. Torrence, C. A. Smith, R. G. Goodwin, K. E. Stremler, V. P. Fung, H. Madani, and M. B. Widmer. 1993. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1548.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: a Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 1.21-1.84.
30. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513.
31. Hitt, M., A. J. Bett, L. Prevec, and F. L. Graham. 1994. Construction and propagation of human adenovirus vectors. In Cell Biology: A Laboratory Handbook. J. E. Celis, ed. Academic Press, San Diego, CA, p. 479.
32. Bett, A. J., W. Haddara, L. Prevec, and F. L. Graham. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91:8802.
33. Bakker-Woudenberg I. A. J. M., A. F. Lokerse, M. T. ten Kate, J. W. Mouton, M. C. Woodle, and G. Storm. 1993. Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. J. Infect. Dis. 168:164.
34. McColm A. A., E. Shelley, D. M. Ryan, and P. Acred. 1986. Evaluation of ceftazidime in experimental Klebsiella pneumoniae pneumonia: comparison with other antibiotics and measurement of its penetration into respiratory tissues and secretions. J. Antimicrob. Chemother. 18:599.
35. VanOtteren, G. M., T. J. Standiford, S. L. Kunkel, J. M. Danforth, M. D. Burdick, L. Abruzzo, and R. M. Stricter. 1994 The expression and regulation of macrophage inflammatory protein 1 alpha by murine alveolar and peritoneal macrophages. Am. J. Respir. Cell. Mol. Biol. 10:8.
36. Chehimi, J., and Trinchieri, G. 1994. Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 14:149.
37. Metzger, D. W., R. Raeder, V. H. Van Cleave, and M. D. P. Boyle. 1995. Protection of mice from group A streptococcal skin infection by interleukin-12. J. Infect. Dis. 171:1643.
38. Greenberger, M. J., R. M. Stricter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155:722.
39. Nelson, S., C. Nakamura, and J. Shellito. 1992. Intratracheal gamma-interferon enhances pulmonary host defenses against Pseudomonas aeruginosa. Am. Rev. Respir Dis. 145S:337.
40. Nelson S., G. J. Bagby, and W. Summer. 1991. Anti-tumor necrosis factor-alpha antibody suppresses pulmonary anti-bacterial defenses. Am. Rev. Respir. Dis. 143S:393.
41. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon-γ in defense against murine cytomegalo-virus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045.
42. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, and G. Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
43. Tripp, D. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor a are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3275.
44. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
45. Yang, Y., G. Trinchieri, and J. M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1:890.